Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
7.80
-0.33 (-4.06%)
Aug 8, 2025, 12:47 PM - Market open
Sumo Logic Employees
Aligos Therapeutics had 70 employees as of December 31, 2024. The number of employees increased by 4 or 6.06% compared to the previous year.
Employees
70
Change (1Y)
4
Growth (1Y)
6.06%
Revenue / Employee
$45,343
Profits / Employee
-$1,059,771
Market Cap
47.98M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 70 | 4 | 6.06% |
Dec 31, 2023 | 66 | -17 | -20.48% |
Dec 31, 2022 | 83 | -10 | -10.75% |
Dec 31, 2021 | 93 | 19 | 25.68% |
Dec 31, 2020 | 74 | 13 | 21.31% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALGS News
- 1 day ago - Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results - GlobeNewsWire
- 8 days ago - Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 4 weeks ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC) - GlobeNewsWire
- 2 months ago - Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal - GlobeNewsWire
- 3 months ago - Aligos Therapeutics Presents Positive Data at the EASL Congress 2025 - GlobeNewsWire
- 3 months ago - Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results - GlobeNewsWire